Therapy

Drug trials

Small and medium-size contract research organisations (CROs) have huge potential. For the last few decades, pharmaceutical companies have increasingly chosen to use medium-size contract research organisations (CROs), or smaller organisations, rather than the larger organisations, due to their enhanced responsiveness and flexibility, that provides good geographic coverage, a broad therapeutic…

Photo

Bone Support study is underway

Cerament Spine Support, designed by the medical technology company BoneSupport to treat osteoporotic vertebral compression fractures, has achieved full patient enrolment in an open, multi-centre study which will investigate the product's efficacy, safety, and the beneficial quality of life outcome for the patients. The study, being carried out at six centres in Germany, involves 40 patients aged…

Photo

Article • Freezing cardiology

Cryoablation – a safer therapy for children with arrhythmias

Freezing abnormal electrical pathways in the hearts of young patients may be a safer alternative to zapping them with powerful radiofrequency probes to treat tachycardias and other arrhythmias, according to Dr Fabrizio Drago, of the Bambino Gesù Hospital, Rome. ‘If you have a child with a supraventricular tachycardia due to a re-entry circuit, or a target very close to the atrioventricular…

Photo

Stem Cells

By Professor Gustav Steinhoff MD, director of the Department for Cardiac Surgery, and Christof Stamm MD, co-ordinator of clinical studies, at Rostock University, Germany

Photo

Appendicitis complicated by chickenpox

Surgeons Sergey V Stonogin, specialist in infectious cases, Eugeny V Dvorovenko, Head of Emergency Surgery, and Vladimir A Chaplin, endoscopy specialist - report on results from their study to assess the most effective, safe combination of antibiotics to treat patients with acute appendicitis complicated by chickenpox

Liberal drugs policy works

Switzerland - Providing heroin addicts methadone or buprenorphine as a treatment for their addiction has led to a decline in the number of new heroin users in Zurich, according to a paper by Carlos Nordt and Rudolf Stohler from the Psychiatric University Hospital, Zurich, published in The Lancet.

19 show more articles
Subscribe to Newsletter